👩🍳 How we use AI at Tech in Asia, thoughtfully and responsibly.
🧔♂️ A friendly human may check it before it goes live. More news here
🧔♂️ A friendly human may check it before it goes live. More news here
Indian online pharmacy PharmEasy’s valuation drops to $456m
PharmEasy, an Indian online pharmacy, is currently valued at approximately US$456 million.
This is a significant drop from its peak valuation of US$5.6 billion, as reported after investor Janus Henderson disclosed that its 12.9 million shares in the startup were worth US$766,043.
Janus Henderson’s Global Research Fund purchased these shares for US$9.4 million, reflecting a 92% decline in value.
This decrease in valuation continues despite PharmEasy raising over US$200 million earlier this year in preparation for an IPO scheduled for 2025.
Recent PharmEasy developments
| Timeline |
|---|
01-Nov-2021 📈 India Roundup: PharmEasy to file for $934m IPO, and more
|
06-Aug-2021 🦷 PharmEasy co-founders join $20m round of dental care platform Toothsi
|
09-Jul-2021 💊 Report: IPO-bound PharmEasy to raise up to $200m from SoftBank
|
25-Jun-2021 💰 Investor of IPO-bound Pharmeasy hits $30m in final close of its third fund
|
25-May-2021 💊 Indian online healthcare delivery startup PharmEasy acquires rival Medlife
|
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.